AI
CC icon

Atria Investments’s Chemours CC Stock Holding History

Atria Investments’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,939
Closed -$288K – 642
2019
Q4 		$288K Sell
15,939
-51,100
-76% -$849K 0.01% 991
2019
Q3 		$1M Sell
67,039
-7,990
-11% -$130K 0.04% 425
2019
Q2 		$898K Buy
75,029
+63,995
+580% +$1.89M 0.03% 428
2019
Q1 		$410K Buy
+11,034
New +$402K 0.02% 584

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Atria Investments's CC Position: Q1 2020 in Review

Atria Investments sold out of Chemours (CC) in Q1 2020, closing a stake of 15,939 shares — an estimated $288K sold.

Atria Investments first reported a position in CC in Q1 2019 and held it in 4 quarters. The position peaked at $1M in Q3 2019. 416 funds tracked by Wall St. Rank hold CC as of Q1 2020.

  • Atria Investments reported no remaining Chemours position as of Q1 2020 after selling out during the quarter.
  • Atria Investments sold 15,939 Chemours shares in Q1 2020, an estimated $288K.
  • Atria Investments first reported a position in Chemours in Q1 2019 and held it in 4 quarters.
  • Atria Investments's Chemours position peaked at $1M in Q3 2019.
  • 416 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Atria Investments's 13F filing for Q1 2020, filed 15 May 2020.